A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: nobody (4)

Bendamustine_70_Rituximab

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB There are multiple versions of this protoc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-Rituximab.pdf

Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT)

Description
Chemotherapy Protocol UPPER GASTROINTESTINAL CANCER DOCETAXEL-FLUOROURACIL-FOLINIC ACID-OXALIPLATIN (FLOT) Regimen • U
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Docetaxel-Fluorouracil-Folinic-Acid-Oxaliplatin-FLOT.pdf

Appendix B - VZIG risk assessment and prescription form

Description
Varicella zoster Immunoglobulin for post-exposure prophylaxis (PEP)Please note that UHS Pharmacy will issue VZIG only when both RISK ASSESSME
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixB-VZIGRiskAssessmentandPrescriptionForm.pdf

AmB - Cytarabine(1500)

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (1500mg/m2) Ambulatory Regimen This regimen is for AMBULATORY C
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine1500-Ver-1.pdf

AmB - Cytarabine(3000)

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (3000mg/m2) Ambulatory Regimen This regimen is for AMBULATORY C
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine-3000.pdf

Epcoritamab -Cycle 1 (Priming)

Description
Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

Papers CoG - 29.01.2025

Description
Date Time Location Chair Agenda Council of Governors 29/01/2025 14:00 - 15:30 Conference Room, Heartbeat/Microsoft Teams Jenni Dougl
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-29.01.2025.pdf

Benign paroxysmal positional vertigo - patient information

Description
BPPV is a common cause of dizziness. It occurs in people of all ages but is more common in middle-aged
Url
/Media/UHS-website-2019/Patientinformation/Audiology/Benign-paroxysmal-positional-vertigo-1279-PIL.pdf

EC-PPH Cyclophosphamide Epirubicin Paclitaxel Pertuzumab Trastuzumab

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL-PERTUZUMABTRASTUZUMAB (EC-PPH) Regimen • Breast Cancer – C
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/EC-PPH-Cyclophosphamide-Epirubicin-Paclitaxel-Pertuzumab-Trastuzumab.pdf

EC-DPH IV (Cyclophosphamide-Epirubicin-Docetaxel-Pertuzumab-Trastuzumab IV)

Description
Please refer to the most up to date Bluteq eligibility criteria for pertuzumab and trastuzumab before prescribing.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/EC-DPH-IV-Cyclophosphamide-Epirubicin-Docetaxel-Pertuzumab-Trastuzumab-IV.pdf
181 to 190 of 1000
Previous … 17 18 19 20 21 … Next